Wegovy / semaglutide
UK online-provider examples show Wegovy monthly pens from around £80 at starter doses to around £200+ at higher doses. Multi-pen higher-dose bundles may price differently.
GLP / weight loss prescriptions
By the time people search for GLP treatment, they have often had years of “start Monday” plans, food noise, private frustration, or health warnings behind them. This guide explains the main prescription routes, who they may be for, what they can cost privately in £/$ examples, and what a clinician should check before treatment is considered.
Main prescription routes
Once-weekly GLP-1 injection for weight management where eligibility is met. Private pricing can vary by dose, country, consultation fees, and pharmacy route.
TirzepatideOnce-weekly dual GIP/GLP-1 injection used for type 2 diabetes and/or weight management depending on indication and local rules.
CapsulesOral weight loss medicine taken with meals that contain fat. It works differently from GLP injections and has different side-effect trade-offs.
Eligibility
Weight loss prescriptions are usually considered for people with obesity, or people who are overweight with weight-related health risks. Eligibility can depend on BMI, diabetes status, blood pressure, cholesterol, previous weight-loss attempts, pregnancy plans, and medication history.
GLP medicines commonly reduce appetite and help people feel fuller for longer. Orlistat reduces how much fat is absorbed from food. None of these medicines should be treated as risk-free or suitable for everyone.
Private price guide · £ / $
UK online-provider examples show Wegovy monthly pens from around £80 at starter doses to around £200+ at higher doses. Multi-pen higher-dose bundles may price differently.
Private monthly pen examples commonly run higher than Wegovy, with public UK examples around £175–£335 depending on dose.
Generic orlistat is often cheaper than injections. UK online examples show 84 capsules around £45, with branded Xenical around £50+ for a similar pack.
Price note: Use prices as examples only. Check both British pound (£) and US dollar ($) pricing where relevant, because delivery, consultation, subscription, discounts, dose, stock status, pharmacy route, and country rules can alter the final cost.
Customer basics
GLP treatment usually involves dose escalation, appetite change, and possible stomach side effects. The emotional pull is obvious: people want control back. The practical side still matters: protein, nausea, hydration, missed doses, supply issues, follow-up, and what happens if treatment is stopped.
A responsible route should explain storage, injection technique, missed doses, side effects, follow-up, and when to seek medical help. Be cautious with fake medicines, no-consultation sellers, unclear pharmacies, “guaranteed” claims, and unusually cheap injections.
Real-life situations
People do not usually arrive here because of one bad week. They arrive after years of food noise, “I know what to do but I cannot keep doing it”, health warnings, brutal photos, tired joints, or feeling like appetite is harder to control than the rest of life.
This page is here to make the next step less foggy: eligibility, monthly cost, dose support, side effects, delivery, pharmacy route, and what responsible clinician-led care should explain.
Common GLP situations
Often a busy parent or professional in their 30s–40s with years of calorie apps, slimming groups, meal plans, fasting, shakes, and “start Monday” attempts behind them. They know the basics, but appetite, stress, family life, hormones, tiredness, and shame keep pulling them back.
Their trigger is usually a friend losing weight, a brutal photo, a holiday, a wedding, a health scare, or one more failed attempt. They want privacy, no judgement, and a practical answer to “am I eligible, what does it cost, and what should I ask first?”
This customer is usually 40–65 and may have prediabetes, type 2 diabetes, sleep apnoea, high blood pressure, cholesterol issues, joint pain, or family history that worries them. They are not chasing a beach body. They are trying not to become the next family health warning.
They care about legitimacy: side effects, existing medicines, pharmacy standards, monitoring, and whether a cheap route is unsafe.
Usually 28–45, busy, relatively well-paid, and used to private convenience. They may be good at work but frustrated that appetite and weight feel harder to control than everything else in life.
They want to understand speed, stock, discretion, delivery, dose support, total cost, and whether the route looks properly clinician-led. They do not want moral lectures or sketchy sellers.
Why these checks matter
KFF’s May 2024 Health Tracking Poll found about one in eight US adults had ever taken a GLP-1 drug, rising to 43% among adults told by a doctor they had diabetes, 26% among those told they had heart disease, and 22% among those told they were overweight or obese in the previous five years. Most users took them at least partly for a chronic condition, while a smaller but important group used them primarily for weight loss.
The same poll found affordability is a major issue: about half of adults who had taken GLP-1s said the cost was difficult to afford. That is why a useful comparison should make price, what is included, and dose-related cost changes obvious.